61 related articles for article (PubMed ID: 7580976)
1. [Binding characteristics of a specific blocker (3H)-quinuclidinylbenzilate to M-cholinergic receptors from rat cerebral cortex membranes].
Nesterova LA; Smurova EA; Manukhin BN
Dokl Akad Nauk; 1995 Jul; 343(2):268-71. PubMed ID: 7580976
[No Abstract] [Full Text] [Related]
2. The effect of heat shock on M-cholinoreceptors from rat cerebral cortex membranes.
Nesterova LA; Smurova EA; Manukhin BN
Membr Cell Biol; 1997; 11(2):187-94. PubMed ID: 9354398
[TBL] [Abstract][Full Text] [Related]
3. [The effect of paraoxon and sulfhydryl reagents on the binding of 3H-quinuclidinyl benzilate and 3H-methylscopolamine with synaptic membranes of rat cerebral cortex].
Golovko AI; Sofronov GA; Kurganova TA; Kliuntina TV
Biull Eksp Biol Med; 1994 Jul; 118(7):51-3. PubMed ID: 7919274
[No Abstract] [Full Text] [Related]
4. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats.
Araki T; Tanji H; Fujihara K; Kato H; Imai Y; Mizugaki M; Itoyama Y
J Neural Transm (Vienna); 2000; 107(8-9):873-84. PubMed ID: 11041269
[TBL] [Abstract][Full Text] [Related]
5. Cholinergic muscarinic receptor in synaptosomal membranes. Heterogeneity of binding sites for L-[3H]quinuclidinyl benzilate.
Aguilar JS; Salas PJ; De Robertis E
Mol Pharmacol; 1982 Sep; 22(2):304-9. PubMed ID: 7144732
[No Abstract] [Full Text] [Related]
6. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
Luthin GR; Wolfe BB
Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
[TBL] [Abstract][Full Text] [Related]
7. [Modification of selective adsorption of muscarinic antagonists in cerebral membranes during chlorophos poisoning].
Predtechenskiĭ MB; Elaeva NL; Smirnova ZI
Biull Eksp Biol Med; 1989 Oct; 108(10):459-61. PubMed ID: 2597761
[TBL] [Abstract][Full Text] [Related]
8. [Change in the equilibrium binding parameters of (3H)-quinuclidinylbenzilate in rabbit atrial membranes exposed to lysophosphatidylcholine].
Suslova IV; Korotaeva AA; Prokazova NV
Dokl Akad Nauk; 1995 May; 342(2):273-6. PubMed ID: 7633356
[No Abstract] [Full Text] [Related]
9. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
10. [3H]tricyclopinate binding to brain muscarinic acetylcholine receptors: a comparison with [3H]quinuclidinyl benzilate.
Gao ZG; Liu CG
Pharmacol Res; 1996; 33(4-5):283-9. PubMed ID: 8938022
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport.
Zimmerman TW; Binder HJ
Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277
[TBL] [Abstract][Full Text] [Related]
12. Regional circadian variation of acetylcholine muscarinic receptors in the rat brain.
Por SB; Bondy SC
J Neurosci Res; 1981; 6(3):315-8. PubMed ID: 7299844
[TBL] [Abstract][Full Text] [Related]
13. Neuronal function impairment in rabies-infected rat brain.
Tsiang H
J Gen Virol; 1982 Aug; 61 (Pt 2)():277-81. PubMed ID: 7119753
[TBL] [Abstract][Full Text] [Related]
14. Interactions of radiolabelled ligands with specific receptors: an analysis.
Manukhin BN; Nesterova LA; Smurova EA; Kichikulova TP
Membr Cell Biol; 2000; 13(5):667-85. PubMed ID: 10987390
[TBL] [Abstract][Full Text] [Related]
15. Interaction of the neuromuscular blocking drug atracurium with muscarinic acetylcholine receptors.
Musílková J; Starshinova LA; Shelkovnikov SA; Tucek S
Physiol Res; 1991; 40(3):293-304. PubMed ID: 1751476
[TBL] [Abstract][Full Text] [Related]
16. Effect of the NO donor sodium nitroprusside and the NO-synthase inhibitor L-NOARG on the binding of [3H]quinuclidinyl benzylate by muscarinic cholinoreceptors of the rat cerebral cortex.
Nesterova LA; Manukhin BN
Dokl Biol Sci; 2003; 391():322-5. PubMed ID: 14556522
[No Abstract] [Full Text] [Related]
17. [The characteristics of the binding of M-cholinergic blockers and beta-adrenoblockers by the brain synaptosomes of 15-day-old and adult rats].
Manukhin BN; Kichikulova TP; Moskovkin GN
Zh Evol Biokhim Fiziol; 1994; 30(4):525-31. PubMed ID: 7863744
[TBL] [Abstract][Full Text] [Related]
18. Effect of serotonergic receptor activation on the binding of [3H]quinuclidinyl benzylate by membrane muscarinic cholinoreceptors of the rat cerebral cortex.
Nesterova LA; Manukhin BN
Dokl Biol Sci; 2004; 396():260-3. PubMed ID: 15354843
[No Abstract] [Full Text] [Related]
19. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
20. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
